Sensient Technologies targets mid-single-digit revenue growth in 2025 amid natural color expansion and APAC strength Sensient Technologies targets mid-single-digit revenue growth in 2025 amid natural color expansion and APAC strength Post ContentsxtRead More You might also be interested in reading Regeneron’s Eylea injection review dates delayed by FDA. February 14, 2025 In Mainstream ← Previous post Next post →